- Home
- CLGN vs SNAL Comparison
CLGN vs SNAL Comparison
Compare CLGN & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- SNAL
- Stock Information
- Founded
- CLGN 2004
- SNAL 2000
- Country
- CLGN Israel
- SNAL United States
- Employees
- CLGN N/A
- SNAL N/A
- Industry
- CLGN Industrial Specialties
- SNAL Computer Software: Prepackaged Software
- Sector
- CLGN Health Care
- SNAL Technology
- Exchange
- CLGN Nasdaq
- SNAL Nasdaq
- Market Cap
- CLGN 33.8M
- SNAL 33.5M
- IPO Year
- CLGN N/A
- SNAL 2022
- Fundamental
- Price
- CLGN N/A
- SNAL N/A
- Analyst Decision
- CLGN Strong Buy
- SNAL
- Analyst Count
- CLGN 2
- SNAL 0
- Target Price
- CLGN $11.50
- SNAL N/A
- AVG Volume (30 Days)
- CLGN 257.5K
- SNAL 135.2K
- Earning Date
- CLGN 11-26-2025
- SNAL 11-12-2025
- Dividend Yield
- CLGN N/A
- SNAL N/A
- EPS Growth
- CLGN N/A
- SNAL N/A
- EPS
- CLGN N/A
- SNAL N/A
- Revenue
- CLGN $2,402,000.00
- SNAL $91,041,290.00
- Revenue This Year
- CLGN $1,617.28
- SNAL $13.87
- Revenue Next Year
- CLGN $83.54
- SNAL $26.20
- P/E Ratio
- CLGN N/A
- SNAL N/A
- Revenue Growth
- CLGN 248.62
- SNAL 24.25
- 52 Week Low
- CLGN $1.31
- SNAL $0.64
- 52 Week High
- CLGN $4.99
- SNAL $3.42
- Technical
- Relative Strength Index (RSI)
- CLGN 45.87
- SNAL 52.52
- Support Level
- CLGN $2.11
- SNAL $1.00
- Resistance Level
- CLGN $2.44
- SNAL $1.38
- Average True Range (ATR)
- CLGN 0.22
- SNAL 0.13
- MACD
- CLGN -0.03
- SNAL -0.01
- Stochastic Oscillator
- CLGN 23.36
- SNAL 37.19
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.